Javascript must be enabled to continue!
Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy.
View through CrossRef
168 Background: Skeletal muscle loss is associated with physical disability, nosocomial infections, postoperative complications, and decreased survival. Preventing the loss of skeletal muscle mass after gastrectomy may lead to improved outcomes. The aims of this study were to assess changes in skeletal muscle mass after total gastrectomy (TG) and to clarify the clinical factors affecting significant loss of skeletal muscle after TG. Methods: One hundred and two patients undergoing TG for primary gastric cancer underwent abdominal computed tomography (CT) before and 1 year after TG to precisely quantify postoperative changes in skeletal muscle and adipose tissue. Univariate and multivariate logistic regression analyses identified clinical factors contributing to significant loss of skeletal muscle after TG. Results: At 1 year after TG, the mass of both skeletal muscle and adipose tissue was reduced by 6.20±6.80% and 65.8±36.1% of the preoperative values, respectively, and 26 patients (25.5%) showed a significant loss of skeletal muscle of more than 10%. Adjuvant chemotherapy with S-1 for ≥6 months (hazard ratio 26.75, 95% confidence interval 3.511 to 203.9) was identified as the single independent risk factor for a significant loss of skeletal muscle. Conclusions: Skeletal muscle loss was exacerbated by extended adjuvant chemotherapy after TG. Further research should identify appropriate nutritional interventions for maintaining skeletal muscle mass and leading to improved outcomes.
American Society of Clinical Oncology (ASCO)
Title: Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy.
Description:
168 Background: Skeletal muscle loss is associated with physical disability, nosocomial infections, postoperative complications, and decreased survival.
Preventing the loss of skeletal muscle mass after gastrectomy may lead to improved outcomes.
The aims of this study were to assess changes in skeletal muscle mass after total gastrectomy (TG) and to clarify the clinical factors affecting significant loss of skeletal muscle after TG.
Methods: One hundred and two patients undergoing TG for primary gastric cancer underwent abdominal computed tomography (CT) before and 1 year after TG to precisely quantify postoperative changes in skeletal muscle and adipose tissue.
Univariate and multivariate logistic regression analyses identified clinical factors contributing to significant loss of skeletal muscle after TG.
Results: At 1 year after TG, the mass of both skeletal muscle and adipose tissue was reduced by 6.
20±6.
80% and 65.
8±36.
1% of the preoperative values, respectively, and 26 patients (25.
5%) showed a significant loss of skeletal muscle of more than 10%.
Adjuvant chemotherapy with S-1 for ≥6 months (hazard ratio 26.
75, 95% confidence interval 3.
511 to 203.
9) was identified as the single independent risk factor for a significant loss of skeletal muscle.
Conclusions: Skeletal muscle loss was exacerbated by extended adjuvant chemotherapy after TG.
Further research should identify appropriate nutritional interventions for maintaining skeletal muscle mass and leading to improved outcomes.
Related Results
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives:
Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract
Introduction
Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
5. All That glitters is not gold
5. All That glitters is not gold
Abstract
Introduction
Inflammatory muscle disease is a rare but well-recognised manifestation of systemic vasculitis. It can pre...
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
Abstract
Background
Leukocytes play an important role in cancer development. However, the impact of chemotherapy-associated neutropenia/lymphopen...
Outcomes of combined HCC-cholangiocarcinoma with adjuvant chemotherapy: An NCDB cohort.
Outcomes of combined HCC-cholangiocarcinoma with adjuvant chemotherapy: An NCDB cohort.
4166
Background:
Combined (or mixed) hepatocellular carcinoma-cholangiocarcinomas (cHCC-CCA) are rare ...
Correlation between female body mass and functional movements and skeletal muscle mass
Correlation between female body mass and functional movements and skeletal muscle mass
Objective: To investigate the correlation between body mass and functional movements with skeletal muscle mass and skeletal muscle distribution in women, to determine the associati...

